Ultrasound-detectable Endotracheal Tube: a Feasibility Study
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- John R. Charpie
- Study ID
- NCT05941013
- Status
- Recruiting
Conditions
- Cardiac Catheterization
- Endotracheal Tube
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Months - 42 Months
- Healthy Volunteers
- Not accepted
Interventions
- Ultrasound detectable cuffed endotracheal tube (USD-ETT) — DEVICEIntubation with a novel ultrasound-detectable endotracheal tube
Study Details
The researchers are studying whether special features make it easier to see if the breathing tube is in the correct place. It is hoped that the investigational device will enable more accurate placement (depth and trachea vs. esophagus).
Key Dates
- Start date
- Nov 15, 2023
- Status verified
- Feb 2026
- Primary completion
- Mar 31, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Ultrasound detectable cuffed endotracheal tube (USD-ETT)Intubation with a novel ultrasound-detectable endotracheal tube
Primary Outcome Measure
Proportion of the USD-ETTs visualized by ultrasound [ Time Frame: Within 5 minutes of placing the ultrasound probe at the suprasternal notch after intubation ]
Central Contacts
- Cynthia Smith, RN734-615-0590
- Andrea Les, PhD734-998-5585
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | John Charpie, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
By research site
Related Studies
- Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in WomenEnrolling By Invitation · Yale University · New Haven, Connecticut
- GSI Cardiac on Revolution Apex - USRecruiting · GE Healthcare · Seattle, Washington